Oncopro KRAS Rapid Test sale cost 3510 AED
Cancer Targeted Gene Panel Colon Colorectal Test sale cost 2970 AED Cancer Targeted Gene Panel Colon Colorectal Test Cost 3,960 د.إ Original price was: 3,960 د.إ.2,970 د.إCurrent price is: 2,970 د.إ.
LPL Expert Panel 2 Test sale cost 3280 AED LPL Expert Panel 2 Test Cost 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Sale!

Oncopro KRAS Rapid Test Cost

Original price was: 3,900 د.إ.Current price is: 3,510 د.إ.

-10%

The “Oncopro KRAS Rapid Test” is a cutting-edge diagnostic tool designed for the rapid identification of mutations in the KRAS gene, which are often implicated in various types of cancer, including colorectal, lung, and pancreatic cancers. This test is especially crucial for tailoring cancer treatment strategies, as the presence of specific KRAS mutations can influence a patient’s response to certain therapies. By quickly determining the KRAS mutation status, healthcare providers can make informed decisions about the most effective treatment plans for their patients, potentially improving outcomes.

The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities and commitment to precision medicine. The cost of the Oncopro KRAS Rapid Test is 3510 AED, reflecting the sophisticated technology and expertise involved in delivering accurate and timely results. This investment in personalized cancer diagnostics represents a significant step forward in optimizing patient care and enhancing the efficacy of targeted therapy regimens.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO KRAS RAPID Test

Test Name: ONCOPRO KRAS RAPID Test

Components: Real Time PCR

Price: 3510.0 AED

Sample Condition: Submit formalin fixed paraffin embedded (FFPE) tissue block. Ship at room temperature. Block should have at least 10% tumor tissue.

Report Delivery: Sample daily by 11 am; Report next working day

Test Type: Cancer

Doctor: Oncologist

Test Department: Molecular Diagnostics

Pre Test Information: Block should have at least 10% tumor tissue.

Test Details

The ONCOPRO KRAS RAPID Test is a diagnostic test used to detect mutations in the KRAS gene. KRAS mutations are commonly found in various types of cancers, including colorectal, lung, and pancreatic cancer.

The test is designed to provide rapid and accurate results, allowing healthcare professionals to quickly determine if a patient’s cancer is driven by KRAS mutations. This information is crucial for guiding treatment decisions, as certain targeted therapies are only effective in patients without KRAS mutations.

The ONCOPRO KRAS RAPID Test is typically performed using a tissue sample from the tumor. The test utilizes a polymerase chain reaction (PCR) technique to amplify and analyze the DNA for specific KRAS mutations. Results are typically available within a few hours, allowing for timely treatment decisions.

Overall, the ONCOPRO KRAS RAPID Test is an important tool in personalized medicine, helping to identify patients who may benefit from targeted therapies and improving patient outcomes.

Test Name ONCOPRO KRAS RAPID Test
Components
Price 3510.0 AED
Sample Condition Submit formalin fixed paraffin embedded (FFPE) tissue block.Ship at room temperature. Block should have atleast 10% tumor tissue.
Report Delivery Sample Daily by 11 am; Report Next Working day
Method Real Time PCR
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Block should have atleast 10% tumor tissue.
Test Details

The ONCOPRO KRAS RAPID Test is a diagnostic test used to detect mutations in the KRAS gene. KRAS mutations are commonly found in various types of cancers, including colorectal, lung, and pancreatic cancer.

The test is designed to provide rapid and accurate results, allowing healthcare professionals to quickly determine if a patient’s cancer is driven by KRAS mutations. This information is crucial for guiding treatment decisions, as certain targeted therapies are only effective in patients without KRAS mutations.

The ONCOPRO KRAS RAPID Test is typically performed using a tissue sample from the tumor. The test utilizes a polymerase chain reaction (PCR) technique to amplify and analyze the DNA for specific KRAS mutations. Results are typically available within a few hours, allowing for timely treatment decisions.

Overall, the ONCOPRO KRAS RAPID Test is an important tool in personalized medicine, helping to identify patients who may benefit from targeted therapies and improving patient outcomes.

SKU: TEST-4728 Category:

Related products